351 related articles for article (PubMed ID: 32281186)
1. Translational hurdles with cannabis medicines.
Graham M; Lucas CJ; Schneider J; Martin JH; Hall W
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1325-1330. PubMed ID: 32281186
[TBL] [Abstract][Full Text] [Related]
2. Real World Evidence in Medical Cannabis Research.
Banerjee R; Erridge S; Salazar O; Mangal N; Couch D; Pacchetti B; Sodergren MH
Ther Innov Regul Sci; 2022 Jan; 56(1):8-14. PubMed ID: 34748204
[TBL] [Abstract][Full Text] [Related]
3. Use of Real-World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018-2019.
Eskola SM; Leufkens HGM; Bate A; De Bruin ML; Gardarsdottir H
Clin Pharmacol Ther; 2022 Jan; 111(1):310-320. PubMed ID: 34689334
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Aviram J; Samuelly-Leichtag G
Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Häuser W; Petzke F; Fitzcharles MA
Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
[TBL] [Abstract][Full Text] [Related]
6. Marketing Authorization Applications Made to the European Medicines Agency in 2018-2019: What was the Contribution of Real-World Evidence?
Flynn R; Plueschke K; Quinten C; Strassmann V; Duijnhoven RG; Gordillo-Marañon M; Rueckbeil M; Cohet C; Kurz X
Clin Pharmacol Ther; 2022 Jan; 111(1):90-97. PubMed ID: 34689339
[TBL] [Abstract][Full Text] [Related]
7. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Krcevski-Skvarc N; Wells C; Häuser W
Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
[TBL] [Abstract][Full Text] [Related]
8. How can real-world evidence aid decision making during the life cycle of nonprescription medicines?
Csoke E; Landes S; Francis MJ; Ma L; Teotico Pohlhaus D; Anquez-Traxler C
Clin Transl Sci; 2022 Jan; 15(1):43-54. PubMed ID: 34405554
[TBL] [Abstract][Full Text] [Related]
9. Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness.
Mahendraratnam N; Mercon K; Gill M; Benzing L; McClellan MB
Clin Pharmacol Ther; 2022 Jan; 111(1):150-154. PubMed ID: 33891318
[TBL] [Abstract][Full Text] [Related]
10. Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics.
Schlag AK; O'Sullivan SE; Zafar RR; Nutt DJ
Neuropharmacology; 2021 Jun; 191():108586. PubMed ID: 33940011
[TBL] [Abstract][Full Text] [Related]
11. Use of real-world evidence for oncology clinical decision making in emerging economies.
Petracci F; Ghai C; Pangilinan A; Suarez LA; Uehara R; Ghosn M
Future Oncol; 2021 Aug; 17(22):2951-2960. PubMed ID: 34044583
[TBL] [Abstract][Full Text] [Related]
12. Real-World Evidence: A Primer.
Dang A
Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
[TBL] [Abstract][Full Text] [Related]
13. The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications.
Purpura CA; Garry EM; Honig N; Case A; Rassen JA
Clin Pharmacol Ther; 2022 Jan; 111(1):135-144. PubMed ID: 34726771
[TBL] [Abstract][Full Text] [Related]
14. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
15. Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective.
Azoulay L
Oncologist; 2022 Sep; 27(9):e731-e738. PubMed ID: 35762676
[TBL] [Abstract][Full Text] [Related]
16. [Real-world evidence : Benefits and limitations in multiple sclerosis research].
Ziemssen T; Rothenbacher D; Kuhle J; Berger T
Nervenarzt; 2017 Oct; 88(10):1153-1158. PubMed ID: 28776214
[TBL] [Abstract][Full Text] [Related]
17. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.
Feinberg BA; Gajra A; Zettler ME; Phillips TD; Phillips EG; Kish JK
Value Health; 2020 Oct; 23(10):1358-1365. PubMed ID: 33032780
[TBL] [Abstract][Full Text] [Related]
18. Proceed with Caution When Using Real World Data and Real World Evidence.
Kim HS; Kim JH
J Korean Med Sci; 2019 Jan; 34(4):e28. PubMed ID: 30686950
[TBL] [Abstract][Full Text] [Related]
19. Benefits and limitations of real-world evidence: lessons from
Nazha B; Yang JC; Owonikoko TK
Future Oncol; 2021 Mar; 17(8):965-977. PubMed ID: 33242257
[TBL] [Abstract][Full Text] [Related]
20. Payer perceptions of the use of real-world evidence in oncology-based decision making.
Brixner D; Biskupiak J; Oderda G; Burgoyne D; Malone DC; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Aug; 27(8):1096-1105. PubMed ID: 34337998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
